title: Proceed with caution: peginterferon alpha-2a versus peginterferon alfa-2b in chronic hepatitis C. A systematic review of randomized trials.
authors.forename: David
authors.initials: D
authors.lastname: Kershenobich
authors.forename: Linda
authors.initials: L
authors.lastname: Muñoz
authors.forename: René
authors.initials: R
authors.lastname: Malé
authors.forename: Jesús
authors.initials: J
authors.lastname: Gaytan
authors.forename: Francisco
authors.initials: F
authors.lastname: Sánchez
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D015201:Meta-Analysis as Topic; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b; C100416:peginterferon alfa-2a